Discovery of a New Class of Ionotropic Glutamate Receptor Antagonists by the Rational Design of (2S3R)-3-(3-Carboxyphenyl)-pyrrolidine-2-carboxylic Acid

摘要

The kainic acid (KA) receptors belong to the class of glutamate (Glu) receptors in the brain and constitute a promising target for the treatment of neurological and/or psychiatric diseases such as schizophrenia, major depression, and epilepsy. Five KA subtypes have been identified and named GluK1−5. In this article, we present the discovery of (2S,3R)-3-(3-carboxyphenyl)-pyrrolidine-2-carboxylic acid (>1) based on a rational design process. Target compound >1 was synthesized by a stereoselective strategy in 10 steps from commercially available starting materials. Binding affinities of >1 at native ionotropic Glu receptors were determined to be in the micromolar range (AMPA, 51 μM; KA, 22 μM; NMDA 6 μM), with the highest affinity for cloned homomeric KA receptor subtypes GluK1,3 (3.0 and 8.1 μM, respectively). Functional characterization of >1 by two electrode voltage clamp (TEVC) electrophysiology at a nondesensitizing mutant of GluK1 showed full competitive antagonistic behavior with a Kb of 11.4 μM.